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Abstract
Background: Human parvovirus B19 (B19) is known to induce apoptosis that has been associated with a variety of 
autoimmune disorders. Although we have previously reported that B19 non-structural protein (NS1) induces 
mitochondrial-dependent apoptosis in COS-7 cells, the precise mechanism of B19-NS1 in developing autoimmunity is 
still obscure.
Methods: To further examine the effect of B19-NS1 in presence of autoantigens, COS-7 cells were transfected with 
pEGFP, pEGFP-B19-NS1 and pEGFP-NS1K334E, a mutant form of B19-NS1, and detected the expressions of 
autoantigens by various autoantibodies against Sm, U1 small nuclear ribonucleoprotein (U1-snRNP), SSA/Ro, SSB/La, 
Scl-70, Jo-1, Ku, and centromere protein (CENP) A/B by using Immunoblotting.
Results: Significantly increased apoptosis was detected in COS-7 cells transfected with pEGFP-B19-NS1 compared to 
those transfected with pEGFP. Meanwhile, the apoptotic 70 kDa U1-snRNP protein in COS-7 cells transfected with 
pEGFP-B19-NS1 is cleaved by caspase-3 and converted into a specific 40 kDa product, which were recognized by anti-
U1-snRNP autoantibody. In contrast, significantly decreased apoptosis and cleaved 40 kDa product were observed in 
COS-7 cells transfected with pEGFP-NS1K334E compared to those transfected with pEGFP-B19-NS1.
Conclusions: These findings suggested crucial association of B19-NS1 in development of autoimmunity by inducing 
apoptosis and specific cleavage of 70 kDa U1-snRNP.
Background
Human parvovirus B19 (B19) has been associated with
the development of various autoimmune disorders [1-7].
Evidences have indicated that many clinical features in
patients with acute or chronic B19 infection are
extremely similar to those with autoimmune diseases,
including the elevated levels of autoantibodies [5,6,8-10].
However, the molecular basis and pathogenesis of B19-
induced autoimmunity is still unclear.
B19 was firstly discovered in 1975 and known as a
human pathogen [11]. The genome of B19 consists of
three encoding regions including the nonstructural pro-
tein (NS1) and two capsid proteins, VP1 and VP2 [3,12].
B19-NS1 protein has been reported to act as a transacti-
vator of the B19 viral p6 and various cellular promoters
including tumor necrosis factor-α (TNF-α) or interleukin
(IL)-6 [13-16]. Additionally, B19-NS1 is known to be
involved in DNA replication, cell cycle arrest and the ini-
tiation of apoptosis in erythroid lineage and non-eryth-
roid lineage cells [17-20]. Recently, many studies also
implied the roles of B19-NS1 in development of autoim-
munity that could be associated with B19-NS1 induced
apoptosis [16,21,22]. However, no further investigation
was performed or reported.
Apoptosis is known as a predominant cause for leakage
of various autoantigens such as nucleosomal DNA, SSA/
Ro, SSB/La, U1 small nuclear ribonucleoprotein (U1-
snRNP) and phospholipid in patients with SLE or
antiphospholipid syndrome (APS) [23-25]. The U1-
snRNP complex is a common target for autoantibodies in
serum of patients with SLE or mixed connective tissue
disease (MCTD) [26,27]. Previous studies have demon-
strated a specific cleavage of the 70-kDa protein compo-
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is recognized as a biochemical feature of apoptotic cell
death [23,24,28]. The cleaved 70-kDa U1-snRNP will be
converted into a C-terminally truncated 40-kDa protein
fragment. Additionally, high recognition of the 40-kd
apoptotic fragment of 70 kDa U1-snRNP has been shown
to correlate with the presence of lupus-like skin disease in
patients with anti-U1-70 kDa antibodies [29]. These find-
ings indicated that apoptotically modified 70 kDa U1-
snRNP is a candidate to drive anti-RNP reactivity in auto-
immune disorders.
Previously, we had firstly reported the mitochondrial
related apoptosis in B19 NS1-transfected epithelial COS-
7 cells, which provides alternative information for B19-
NS1 protein in B19 non-permissive cells [19]. In current
study, we further investigated the effects of B19-NS1 in
presence of autoantigens and found the increased specific
cleaved product of 40 kDa U1-snRNP that was recog-
nized by anti-RNP antibodies.
Methods
Patients and serum
Three volunteer in-patients from Division of Allergy,
Immunology and Rheumatology, participated in this
study, approved by Institutional Review Board (IRB), Tai-
chung Veterans General Hospital, Taichung, Taiwan. All
patients were infected with B19 virus and suffered from
MCTD or SLE. The serum samples form the three
patients contains IgG against B19 and RNP (ranges
170.5~181.4 Units). The serum samples from ten healthy
individuals were used as controls. All healthy individuals
and patients willing to volunteer were accepted without
exclusion and diagnosis was made by a single board certi-
fied physician who is also our coauthor (Dr. Der-Yuan
Chen).
Plasmids and site-directed mutagenesis
Plasmid pEGFP-C1 was purchased from CLONTECH
(CLONTECH Laboratories, Palo Alto, CA, USA). Plas-
mid pQE40-NS1, containing the NS1 gene of B19, was
kindly provided by Professor Susanne Modrow, from the
Institute for Medical Microbiology, Universität Regens-
burg, Regensburg, Germany. The NS1 open reading
frame was obtained by PCR by using a 5'primer (5'-GCA-
GATCTATGGAGCTATTT AGAGGGGTG-3') and a 3'
primer (5'-GCGTCGACCTCATAATCTACAAAGC
TTTGC-3') containing Bgl II and Sal I recognition
sequences for subsequent cloning. Amplified B19-NS1
DNA cDNA was ligated into the Bgl II and Sal I cloning
site of the pEGFP-C1 vector (EGFP). The PCR was per-
formed with reagents containing a 0.2 μM primers mix-
ture, 1.25 μM dNTP mixture, 1.5 μM MgCl2, 10 ng
template, and 2.5 U DNA polymerase (Takara, Tokyo,
Japan). The pEGFP-NS1 was then transformed into
DH5α competent cells, which were obtained from Life
Technologies (Life Technologies, Carlsbad, California,
USA). Restriction enzyme digestion, PCR and DNA
sequencing analysis were used to verify the plasmid. A
previous study has indicated that cytotoxic effect of B19-
NS1 was abolished by single substitutions of amino acids
within the NTP-binding domain [30]. To construct the
mutant plasmid of B19-NS1, pEGFP-NS1-K334E, the
QuikChange XL site-Directed Mutagenesis Kit (Strata-
gene, La Jolla, CA) was used to engineer a lysine to glu-
tamic acid (K334E) mutation into the wild-type NS1
expression vector, pEGFP-NS1, with the following oligo-
nucleotide primers: 5'-CCGCCAAGTACAGGAGAAA-
CAAACT-3' (forward primer) and 5'-AGTTTGTTTCT
CCTGTACTTGGCGG-3' (reverse primer). The PCR
reaction was performed according to the manufactures'
instructions. Briefly, the amplification was performed in a
50 μl reaction volume containing 10× reaction buffer, 50
ng of dsDNA template, 200 μM of dNTPs, 125 ng of each
primer and 2.5 units of PfuTurbo DNA polymerase by
using a Perkin-Elmer Gene Amp PCR system 2400. The
PCR products were checked on a 1% agarose gel. Success-
ful mutagenesis was verified by sequencing forwardly and
reversely.
Cell culture and Transfection
COS-7 cells were originally obtained from American type
culture collection (ATCC) (Manassas, Va, USA) and
grown in Dulbecco's modified Eagle medium (DMEM)
supplemented with 10% fetal bovine serum (FBS)
(GIBCO-BRL, Carlsbad, California, USA) at 37°C in a 5%
CO2 incubator. A total of 1 × 106 cells were grown to 70%
confluence in 100 mm2 dishes before transfection. The
transfection reaction was performed by using Lipo-
fectamine plus reagents (Invitrogen, California, USA)
with 2 μg of each plasmid, EGFP, EGFP-NS1 or EGFP-
NS1K334E, according to the manufacturer's instructions.
The cells were then cultured in serum-free DMEM for 12
hrs at 37°C in a 5% CO2 incubator and subsequently in
DMEM with 10% FBS. The stable clones were obtained
by G418 selection at the concentration of 800 mg/ml
(Promega, Madison, Wisconsin, USA) in DMEM contain-
ing 10% FBS. For caspase-9 inhibition, the cells were pre-
treated for 12 h with 10 mM caspase-9 inhibitor (Z-
LEHD-FMK) (Santa Cruz, CA, USA) and the cell lysate
were then collected for Immunoblotting as described in
our previous study [19].
Fluorescence Microscopy
EGFP, EGFP-NS1 and EGFP-NS1K334E expression in
transfected COS-7 cells were observed with a Zeiss Axio-
plan-2 epifluorescence microscope equipped with a fluo-
rescence filter. Digital images of the cells were recorded
by using a spot camera system.
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The procedures for flow cytometric analysis were the
same as used previously.19 The cells (~2 × 106) were fixed
in 75% alcohol for 12-16 hr at 4°C, followed by RNase (1
mg/mL) treatment at 25°C for 30 min and analyzed by a
flow cytometer (FACScan, Becton Dickinson, Bedford,
MA, USA).
RT-PCR
All studies were carried out in a designated PCR-clean
area. RNA was extracted from infected cells using Trizol
reagent (Invitrogene, Carlsbad, California, USA) accord-
ing to the manufacture's instruction. Total RNA was iso-
lated from EGFP, EGFP-NS1 and EGFP-NS1K334E
expression cells. RNA samples were resuspended in
diethyl pyrocarbonate (DEPC)-treated water, quantified,
and then stored at -80°C until use. RNA concentration
and purity were determined by a spectrophotometer by
calculating the ratio of optical density at wavelengths of
260 and 280 nm. The first-strand cDNA for RT-PCR was
synthesized from total RNA (2 μg) using the Promega RT-
PCR system (Promega, Madison, Wisconsin, USA). The
cDNAs encoding human B19 NS1 and GAPDH were
amplified by RT-PCR using the following primer pairs: 5'-
GGGGGGCCAGGGTTAAACCCCAGA -3' (forward
primer for NS1 cDNAs, nt 694-717), 5'-CTTTAACA-
CATGCTGCCCCACCAA-3' (reverse primer for NS1
cDNAs, nt1348-1371), 5'-CCATGGCACCGTCAAGG
CTG A-3' (forward primer for GAPDH cDNAs), and 5'-
TTGGCAGTGGGGACACGGA A-3' (reverse primer for
GAPDH cDNAs). The amplification was performed in a
50 μl reaction volume containing 1× reaction buffer (Pro-
mega, Madison, Wisconsin, USA), 1.5 μM of MgCl2, 200
μM of dNTPs, 1 μM of each primer and 2.5 units of Taq
DNA polymerase (Promega, Madison, Wisconsin, USA)
using a Perkin-Elmer Gene Amp PCR system 2400. Each
cycle consists of denaturation at 95°C for 1 min, anneal-
ing at 55°C for 45 sec, and amplification at 72°C for 45
sec. The RT-PCR derived DNA fragments obtained by 30
PCR cycles were subjected to electrophoresis on a 1.7%
agarose gel.
Caspase 3 activity assay
A caspase-3 ELISA kit (BD Pharmingen, San Diego, Cali-
fornia, USA) was used for in vitro determination of cas-
pase-3 activity in cell lysates according to manufacturer's
instruction.
Immunoblotting
The COS-7 cells transfected with different plasmids were
lysed in an aliquot volume of 600 ul PRO-PREP® solution
(iNtRON Biotech, Korea) for 30 min on ice. The cell
lysates were then centrifuged at 15,000 rpm for 10 min at
4°C and the supernatant was isolated and stored at -80°C
until use. Protein concentration was determined accord-
ing to the method described by Bradford [31]. Thirty μg
of each protein sample were applied and separated onto a
12.5% sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) [32] at 100-120 V for 1.5 hr before
transferred to the nitrocellulose membranes [33]. The
membranes were then cut into strips and soaked in 5%
nonfat dry milk in PBS for 30 min at room temperature to
saturate irrelevant protein binding sites. Antibodies
against actin (Upstates, Charlottesville, Virginia, USA),
Cleaved Caspase-3 (Asp175), Cleaved Caspase-9
(Asp315) (Cell Signaling, Massachusetts, USA) and Bax,
Ku70/Ku-86 (Santa Cruz, CA, USA), SSA/Ro, SSB/La,
Scl-70, Jo-1 (MBL, Nagoya, Japan), Sm, U1-snRNP, CENP
A and B (INOVA Diagnostics, Inc San Diego, CA, USA),
and B19-NS1 [16,19], were diluted in PBS with 2.5% BSA
and incubated for 1.5 hr with gentle agitation at room
temperature. The antigen-antibody was then hybridized
with horseradish peroxidase (HRP) conjugated secondary
antibody and detected with Pierce's Supersignal West
Dura HRP Detection Kit (Pierce Biotechnology Inc.,
Rockford, IL). Quantified results were performed by den-
sitometry (Appraise, Beckman-Coulter, Brea, California,
USA).
Statistical analysis
Statistical analysis was performed using the paired t test.
Correlation between variables was assessed by Spear-
man's correlation coefficient and Pearson correlation.
Regression parameter at 0.05 probability was considered
significant.
Results
Expression of EGFP, EGFP-NS1 and EGFP-NS1K334E in COS-
7 cells
Constructions of pEGFP, pEGFP-NS1, and pEGFP-
NS1K334E and the stable clones of COS-7 cells were per-
formed as described in materials and methods. The
expression of EGFP, EGFP-NS1, and EGFP-NS1K334E in
COS-7 cells were examined and confirmed with fluores-
cence microscope, flowcytometry, RT-PCR and immuno-
blots. The COS-7 cells transfected with pEGFP, pEGFP-
NS1, or pEGFP-NS1K334E were observed under phase
contrast and fluorescence microscope (Fig 1A). Markedly
green fluorescence was observed in all transfectants (Fig
1A, middle panel) as well as the fluorescence shift
detected by flowcytometry (Fig 1A, lower panel). To fur-
ther confirm the expression of EGFP, EGFP-NS1, and
EGFP-NS1K334E in COS-7 cells, RNA and protein
expressions of NS1 were examined. Figure 1B revealed
the RT-PCR results of B19-NS1. Expression of B19-NS1
was detected in COS-7 cells transfected with pEGFP-NS1
and pEGFP-NS1K334E but not pEGFP. Additionally,
expressions of B19-NS1 protein were detected in COS-7
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Figure 1 Expression of EGFP, EGFP-NS1 and EGFP-NS1K334E. (A) The COS-7 cells transfected with pEGFP, pEGFP-NS1 or pEGFP-NS1K334E were 
observed under phase contrast (upper panel) and fluorescence microscope (middle panel). The fluorescence intensity was also detected using flow-
cytometry (lower panel). The (B) mRNA and (C) protein expressions of B19-NS1 were detected by RT-PCR and Immunoblottings. E, N and K indicate 
EGFP, EGFP-NS1 and EGFP-NS1K334E, respectively.
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NS1K334E but not pEGFP (Fig 1C).
Presence of apoptosis in COS-7 cells transfected with 
pEGFP, pEGFP-NS1 and pEGFP-NS1K334E
To confirm the presence of apoptosis in COS-7 cells
transfected with pEGFP, pEGFP-NS1, and pEGFP-
NS1K334E, caspase-3 activity assay and immunoblottings
were performed. Significantly higher activity of caspase-3
was detected in COS-7 cells transfected with pEGFP-NS1
compared to those transfected with pEGFP. In contrast,
significantly reduced caspase-3 activity was observed in
COS-7 cells transfected with pEGFP-NS1K334E com-
pared to those transfected with pEGFP-NS1 (Fig 2A).
Similar results were found in expressions of mitochon-
drial dependent apoptotic components including cas-
pase-3, Bax and caspase-9 proteins. Significantly higher
expressions of activated caspase-3, Bax, activated cas-
pase-9 proteins were detected in COS-7 cells transfected
with pEGFP-NS1 compared to those transfected with
pEGFP whereas the significantly reduced levels of acti-
vated caspase 3, Bax, activated caspase-9 proteins were
observed in COS-7 cells detected pEGFP-NS1K334E
compared to those transfected with pEGFP-NS1 (Fig 2B,
2C and 2D).
Cleavage apoptotic70-kDa U1-snRNP protein in COS-7 cells 
transfected with pEGFP-NS1
Since B19-NS1 has been known to induce apoptosis and
linked to the pathogenesis of autoimmune disorders,
herein we further examined the presence of various
autoantigens, including Sm, U1-snRNP, SSA, SSB, Scl-70,
Jo-1, Ku, CENP-A/B. The presence of Sm, U1-snRNP, Ku,
SSA, SSB and Jo-1 was detected in COS-7 cells trans-
fected with pEGFP, pEGFP-NS1 and pEGFP-NS1K334E,
whereas no expression of Scl-70, and CENP-A/B proteins
were detected (Fig 3). Interestingly, a 40 kDa protein that
was recognized by antibody against 70 kDa U1-snRNP
was markedly increased in COS-7 cells transfected with
pEGFP-NS1 (Fig 3, middle panel). In contrast, less pres-
ence of 40 kDa protein was observed in COS-7 cells
transfected with pEGFP-NS1k334E (Fig 3, lower panel
and 3B). Additionally, the 40 kDa U1-snRNP in COS-7
cells transfected with pEGFP-NS1 was markedly reduced
in the presence of caspase-9 inhibitor (Fig 3C). Mean-
while, significant correlation was found between caspase-
3 activity and 40 kDa U1-snRNP/actin ratio in COS-7
cells transfected with pEGFP-NS1 (Fig 4A, r = 0.82).
Meanwhile, caspases-9 activity was also significantly cor-
related to the 40 kDa U1-snRNP/actin ratio in COS-7
cells transfected with pEGFP-NS1 (Fig 4B, r = 0.89). To
further verify the association among the cleaved 70 kDa
U1-snRNP, B 19 infection and autoimmunity, serum sam-
ples from 3 different B 19 infected patients with MCTD
or SLE were used to detect the U1-snRNP in COS-7 cells
transfected with pEGFP, pEGFP-NS1 and pEGFP-
NS1K334E. The presence of 40 kDa U1-snRNP was rec-
ognized by all serum samples in pEGFP-NS1 transfected
COS-7 cells (Fig 5).
Discussion
Human parvovirus B 19-NS1 has been known to induce
apoptosis that may contribute to the development of
autoimmunity. However, no further evidence about the
mechanism was reported. In current study, we reported
the significantly increased cleaved 40 kDa-U1-RNP in
COS-7 cells transfected with pEGFP-NS1 compared to
those transfected with pEGFP. In contrast, significantly
reduced 40 kDa-U1-RNP product was observed in COS-
7 cells transfected with pEGFP-NS1K334E as well as the
apparently reduced caspase-3 activity and apoptosis.
Apoptosis is a leading cause of autoantigens, which
have been increasingly recognized as crucial targets of
autoantibodies across a broad spectrum of autoimmune
disorders such as SLE and antiphospholipid syndrome
(APS) [23-25]. Previously, B 19-NS1 has been reported to
play crucial roles in cell cycle arrest and apoptosis in both
erythroid lineage cells [17,18] and non-erythroid lineage
cells [19,20]. A recent study also reported that over-
expressed B 19-NS1 triggers activation of caspase-3 and
degradation of Na+/H+ exchanger, which may contribute
to apoptosis and thus participate in the pathological pro-
cess [34]. Besides, the cytotoxic effect of B 19-NS1 can be
abolished by a single substitution of amino acids within
the NTP-binding domain [30] and has been directly
related to the induction of apoptosis [35,36], which was
used as a negative control of B 19-NS1. Although these
findings have demonstrated the association between B19-
NS1 and apoptosis, however, no evidence is provided
about the effect of mutated B19-NS1 on apoptosis. In this
study, we revealed the significantly increased apoptosis in
COS-7 cells transfected with pEGFP-NS1 compared to
those transfected with pEGFP. In contrast, significantly
reduced apoptosis was observed in COS-7 cells trans-
fected with pEGFP-NS1K334E compared to those trans-
fected with pEGFP-NS1. These data suggest that B19-
NS1 induced apoptosis is probably associated with the
cytotoxic effect of B19-NS1. However, further investiga-
tion is still needed to verify the details.
Growing evidences suggest that deregulation of apop-
tosis is involved in development of autoimmunity.
Indeed, various apoptotic cell antigens, including frag-
mented endoplasmic reticulum, ribosomes, ribonucleo-
protein, nucleosomal DNA, SSA/Ro, SSB/La, and small
nuclear ribonucleoproteins, have been recognized as tar-
gets of autoantibodies across a broad spectrum of auto-
immune diseases [23-25,37]. Moreover, various
autoantigenic proteins are cleaved during apoptosis by
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nases [37,38]. The specific 70 kDa U1-snRNP protein is
known as an autoantigenic protein for autoantibodies in
serum from the patients with SLE or MCTD [26,27]. The
specific 70 kDa U1-snRNP, cleaved during apoptosis by
caspase 3 [23,24] and caspase 9 [28] and converted it into
a C-terminally truncated 40 kDa protein fragment. High
recognition of the 40-kd apoptotic fragment of U1-70
kDa has been shown to correlate with the presence of
lupus-like skin disease in patients with antibodies against
Figure 2 Presence of apoptosis in COS-7 cells transfected with pEGFP, pEGFP-NS1 and pEGFP-NS1K334E. (A) The activity of caspase-3, (B) pres-
ence of activated caspase-3, (C) Bax and (D) activated caspase-9 were detected by ELISA or Immunoblottings. E, N and K indicate EGFP, EGFP-NS1 and 
EGFP-NS1K334E, respectively. * and # indicate significant difference as compared to E or N , respectively.
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Figure 3 Cleavage of 70 kDa U1-snRNP in COS-7 cells transfected with pEGFP-NS1. (A) Expression of various autoantigens including 70 kDa U1-
snRNP, Sm, Ku, CENPA/B, Scl-70, SSA/Ro, SSB/La and Jo-1 (lane 1-2, 5-7, 9-11) were detected in COS-7 cells transfected with pEGFP, pEGFP-NS1 and 
pEGFP-NS1K334E by various antibodies. Actin is used as control (lane 3) and arrow indicates a cleaved 40 kDa U1-snRNP protein. (B) Ratio of 40 kDa 
U1-snRNP to actin. (C) The presence of 70 kDa and 40 kDa U1-snRNP were detected in COS-7 cells transfected with (lanes 1 to 4) pEGFP, pEGFP-NS1, 
pEGFP-NS1K334E and pEGFP-NS1 with caspase-9 inhibitor by antibodies against U1-snRNP. (Lane 5) Actin is used as control. Three independent tests 
were performed. * and # indicate significant difference as compared to E or N, respectively. E, N and K indicate EGFP, EGFP-NS1 and EGFP-NS1K334E, 
respectively.
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fied 70 kDa U1-snRNP antigen is considered as a candi-
date to drive anti-RNP autoimmunity in lupus. As shown
in current study, significant increase of cleaved 40 kDa
fragment from the specific 70 kDa U1-snRNP protein
was observed in COS-7 cells transfected with pEGFP-
NS1 but not in those transfected with pEGFP-NS1K334E,
which has high correlations with increased caspase-3 and
caspase-9 activities. Since the serum from B19 infected
patients with MCTD or SLE recognized the B19-NS1-
induced cleavage of 70 kDa U1-snRNP, however, it could
suggest the association between B19-NS1 induced cleav-
age of 70 kDa U1-snRNP by B19-NS1 and autoimmunity.
Although the precise role of NS1 in inducing autoimmu-
nity is still obscure, here we firstly report the increased
cleaved 40 kDa RNP is associated with B19-NS1 and rec-
ognized by B19 infected patients. that has been recog-
nized as an indicator for development of autoimmunity.
Conclusion
Altogether, we have indicated that B19-NS1 induced
apoptosis is probably associated with the cytotoxic effect
Figure 4 Correlation of (A) caspase-3 activity and (B) caspases-9 
to the 40 kDa U1-RNP in COS-7 cells transfected with pEGFP-NS1.
Figure 5 Recognition of U1-snRNP in COS-7 cells by serum from 
patients with B19 infection. (A) Presence of 70 kDa U1-snRNP and its 
cleaved 40 kDa-form in COS-7 cells transfected with pEGFP, pEGFP-
NS1 and pEGFP-NS1K334E were detected with serum from B19 infect-
ed patients. Lanes 1 to 3 indicate serum from 3 different patients with 
B 19 infection. Actin is used as control (lane 4). Lanes 5 to 6 indicates 
representative results of serum samples that were randomly selected 
from the 10 healthy individuals. (B) Ratio of 40 kDa U1-snRNP to actin. 
Three independent tests were performed. * and # indicate significant 
difference as compared to E or N, respectively. E, N and K indicate EGFP, 
EGFP-NS1 and EGFP-NS1K334E, respectively.
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leads to a specific cleavage of 70 kDa U1-snRNP and is
suggested to play crucial roles in development of autoim-
munity.
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